Specificity, frequency, and phenotype of citrullinated-specific T cells vary with disease activity in rheumatoid arthritis
JCI Insight · 2026
DOI: 10.1172/jci.insight.202159 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2026. Verfasst von Cliff Rims und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Immunology, and. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, CD4-Positive T-Lymphocytes, Citrulline. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, Knut and Alice Wallenberg Foundation.
Abstract (Originalsprache)
In rheumatoid arthritis (RA), CD4 + T cells specific for citrullinated antigens (cit-antigens) are key drivers of disease, but knowledge about epitopes and phenotypes remains limited. We characterized the frequency and phenotype of cit-specific CD4 + T cells in peripheral blood using HLA class II tetramers combined with computational analysis of phenotypic clusters to simultaneously detect peptides derived from 5 cit-antigens (aggrecan, vimentin, fibrinogen, cartilage intermediate layer protein, and α-enolase) previously implicated in RA pathogenesis. In a cross-sectional cohort, cit-aggrecan–, cit-vimentin–, and cit-fibrinogen–specific T cells were more frequent in participants with RA than healthy volunteers, associated with active disease, and had Th1-like and stem-like lineages in RA. In a longitudinal cohort investigating response to therapy, the frequency of cit-aggrecan–, cit-vimentin–, and cit-fibrinogen–specific CD4 + T cells was significantly higher at baseline and further elevated in responders. Furthermore, the frequency of cit-specific Th1-like cells in responders decreased over time. In contrast, the frequency of Th1-like cells in non-responders increased over time. Collectively, these findings demonstrate that cit-specific CD4 + T cells are expanded in RA and target a broad number of antigens across a breadth of phenotypes. Furthermore, the predominant antigen specificities associate with disease activity and exhibit dynamic changes in phenotype that reflect response to therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Immunology, and.
- Center for Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, USA.
- Department of Rheumatology, Virginia Mason Medical Center, Seattle Washington, USA.
- Rheumatology Section, VA Puget Sound Health Care System, Seattle, Washington, USA.
- Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA.
Förderung
- United States Department of Defense
- Knut and Alice Wallenberg Foundation
Zitieren
APA
Rims, C., DeBerg, H. A., Posso, S. E., Muir, V. S., Uchtenhagen, H., Hocking, A. M., Bukiri, H., Carlin, J., Ng, B., Linsley, P. S., James, E. A., & Buckner, J. H. (2026). Specificity, frequency, and phenotype of citrullinated-specific T cells vary with disease activity in rheumatoid arthritis. JCI Insight. https://doi.org/10.1172/jci.insight.202159
Vancouver
Rims C, DeBerg HA, Posso SE, Muir VS, Uchtenhagen H, Hocking AM, et al. Specificity, frequency, and phenotype of citrullinated-specific T cells vary with disease activity in rheumatoid arthritis. JCI Insight. 2026. doi:10.1172/jci.insight.202159
BibTeX
@article{Rims2026,
author = {Rims, Cliff and DeBerg, Hannah A and Posso, Sylvia E and Muir, Virginia S and Uchtenhagen, Hannes and Hocking, Anne M and Bukiri, Heather and Carlin, Jeffrey and Ng, Bernard and Linsley, Peter S and James, Eddie A and Buckner, Jane H},
title = {Specificity, frequency, and phenotype of citrullinated-specific T cells vary with disease activity in rheumatoid arthritis},
journal = {JCI Insight},
year = {2026},
doi = {10.1172/jci.insight.202159}
}
EUVIMED